Junbao Liu
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
- Natural product bioactivities and synthesis
Papers in
-
- Circular RNAs in diseases 3
- Cancer therapeutics and mechanisms 2
-
- Cancer-related molecular mechanisms research 5
- MicroRNA in disease regulation 3
- Cancer, Lipids, and Metabolism 2
- Co-authors
- Yubo Hu (4 shared papers)Cong Ye (1 shared paper)Yu Chen (2 shared papers)Jifeng Feng (1 shared paper)Jianwei Lu (1 shared paper)Weibing Li (1 shared paper)Minjia Sheng (1 shared paper)Yingjian Wang (1 shared paper)
- Journals
- iScience (1 paper)Human Cell (1 paper)Anticancer Research (1 paper)Cancer Medicine (1 paper)OncoTargets and Therapy (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Junbao Liu
19 papers receiving 334 citations
Peers
Comparison fields: 5 of 64
- Cancer Research 149
- Molecular Biology 219
- Pharmacology 17
- Complementary and alternative medicine 13
- Oncology 41
Countries citing papers authored by Junbao Liu
This map shows the geographic impact of Junbao Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junbao Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junbao Liu more than expected).
Fields of papers citing papers by Junbao Liu
This network shows the impact of papers produced by Junbao Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junbao Liu. The network helps show where Junbao Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Junbao Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 74 | |
| 2 | 2017 | 56 | |
| 3 | 2019 | 35 | |
| 4 | 2020 | 24 | |
| 5 | 2016 | 23 | |
| 6 | 2019 | 20 | |
| 7 | 2020 | 18 | |
| 8 | Sequential treatment with betulinic acid followed by 5-fluorouracil shows synergistic cytotoxic activity in ovarian cancer cells. | 2015 | 18 |
| 9 | 2016 | 14 | |
| 10 | 2021 | 12 | |
| 11 | 2023 | 11 | |
| 12 | 2018 | 8 | |
| 13 | 2024 | 6 | |
| 14 | 2014 | 4 | |
| 15 | 2014 | 3 | |
| 16 | 2020 | 3 | |
| 17 | 2018 | 3 | |
| 18 | 2025 | 1 | |
| 19 | 2021 | 1 |
About Junbao Liu
Junbao Liu is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Epidemiology, having authored 19 papers that have together received 334 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (3 papers), Circular RNAs in diseases (3 papers), Cytokine Signaling Pathways and Interactions (2 papers), Cancer therapeutics and mechanisms (2 papers), Cancer, Lipids, and Metabolism (2 papers), Endometriosis Research and Treatment (2 papers) and Reproductive System and Pregnancy (2 papers). The work is most often cited by research in Cancer Research (149 citations), Molecular Biology (219 citations), Pharmacology (17 citations), Complementary and alternative medicine (13 citations) and Oncology (41 citations). Junbao Liu has collaborated with scholars based in China and United States. Frequent co-authors include Yubo Hu, Cong Ye, Yu Chen, Jifeng Feng, Jianwei Lu, Weibing Li, Minjia Sheng, Yingjian Wang, Fangtian Fan and Dan Chen. Their work appears in journals such as iScience, Human Cell, Anticancer Research, Cancer Medicine and OncoTargets and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.